Marcos Edgar Fernandez-Cuadros

Dr. Marcos Edgar Fernandez-Cuadros

Hospital Universitario Santa Cristina, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2020 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
Marcos Edgar Fernandez-CuadrosMarcos Edgar Fernandez-Cuadros
Marcos Edgar Fernandez-Cuadros
MAMaría Jesús Albaladejo-Florín
María Jesús Albaladejo-Florín
DPDaiana Peña-Lora
Daiana Peña-Lora
SÁSandra Álava-Rabasa
Sandra Álava-Rabasa
OPOlga Susana Pérez-Moro
Olga Susana Pérez-Moro

1 January 2019 in Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
Marcos Edgar Fernandez-CuadrosMarcos Edgar Fernandez-Cuadros
Marcos Edgar Fernandez-Cuadros
GGGabriela Goizueta-San-Martin
Gabriela Goizueta-San-Martin
BVBlanca Varas-De-Dios
Blanca Varas-De-Dios
LCLuz Otilia Casique-Bocanegra
Luz Otilia Casique-Bocanegra
PMPablo Manrique-De-Lara-Cadiñanos
Pablo Manrique-De-Lara-Cadiñanos
OPOlga Susana Pérez-Moro
Olga Susana Pérez-Moro
We report the case of a 46-years-old man with long-term asymptomatic hyperuricemia who started taking colchicine (0.5 mg/day) and allopurinol (100 mg/d) for normalization of biochemical values. After the third week of starting treatment, acute weakness was present; and by the fifth week, profound weakness in lower extremities and tenderness and cramps on thighs and calves with inability to climb stairs were also observed. Biochemical evaluation showed elevated muscle enzymes (creatinine kinase [CK] raised to five-folds its normal value) and electromyographic features were consistent with myopathy (at rest, fibrillations, positive sharp waves, high-frequency myotonic discharges; motor unit action potentials [MUAPs] of small amplitude, small duration, increased polyphasic Index and occasional satellite potentials; at maximal effort, interferential recruitment pattern with reduced amplitudes were observed). Normal motor and sensitive nerve conduction studies and normal late F-responses and H-reflex discarded neuropathy. Rapid improvement in muscle strength and prompt resolution of abnormal elevated muscle enzymes was observed after withdrawal of both medications. Colchicine is associated with some cases of myotoxicity but very small cases of colchicine-induced rhabdomyolysis are reported on the literature. Colchicine-induced rhabdomyolysis is related to the concomitant use of drugs (statins, steroids, erythromycin, and cyclosporine), renal, and/or hepatic impairment. To the best of our knowledge, this is an uncommon presentation of a case of colchicine-induced rhabdomyolysis reported in a patient without renal or hepatic dysfunction. Therefore, patients receiving colchicine even in the absence of renal insufficiency should be monitored for the development of myopathy and more rarely to rhabdomyolysis.

3 August 2020 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
Marcos Edgar Fernandez-CuadrosMarcos Edgar Fernandez-Cuadros
Marcos Edgar Fernandez-Cuadros
MAMaría Jesús Albaladejo-Florín
María Jesús Albaladejo-Florín
SÁSandra Álava-Rabasa
Sandra Álava-Rabasa
IUIsabel Usandizaga-Elio
Isabel Usandizaga-Elio
DJDolores Martinez-Quintanilla Jimenez
Dolores Martinez-Quintanilla Jimenez
OPOlga Susana Pérez-Moro
Olga Susana Pérez-Moro

7 July 2016 in American Journal of Men's Health
Verified
Journal Article
Open access
PDF file
Marcos Edgar Fernandez-CuadrosMarcos Edgar Fernandez-Cuadros
Marcos Edgar Fernandez-Cuadros
JNJavier Nieto-Blasco
Javier Nieto-Blasco
AGAntonia Geanini-Yagüez
Antonia Geanini-Yagüez
DCDaniel Ciprián-Nieto
Daniel Ciprián-Nieto
BPBárbara Padilla-Fernández
Bárbara Padilla-Fernández
MLMaria-Fernanda Lorenzo-Gomez
Maria-Fernanda Lorenzo-Gomez
The aim of the current study was to determine the demographic characteristics and risk factors associated with male urinary incontinence (UI) and to assess the effectiveness and the effect on the quality-of-life of a pelvic floor muscle training (PFMT) protocol with electromyography-biofeedback (EMG-BFB) with surface electrodes. A prospective, quasi-experimental before-and-after study with a sample of 61 men out of 372 patients referred to the Pelvic Floor Unit from October 2005 to June 2012 was performed. The protocol consisted of 20 sessions of EMG-BFB supervised by a physiotherapist twice a week. The session durations were 30 minutes (118 work/rest cycles of pelvic muscles). Work lasted 3 seconds and rest 7 seconds. Patients were given standards of conduct and questionnaires (International Consultation on Incontinence–Short Form and Incontinence Quality-of-Life Measure) at the beginning and at the end of the treatment. The average age was 64.85 ± 14.34 years; 44.3% (n = 27) had benign prostatic hypertrophy, 41.9% (n = 25) had prostate malignant neoplasm, 86.9% (n = 53) had undergone prostatectomy, 16.4% (n = 10) had undergone abdominal surgery. Abdominal surgery and radical prostatectomy were significantly associated with UI (p < .05). Stress urinary incontinence was the most common type of UI (86.67%), followed by mixed urinary incontinence (8.33%) and urge urinary incontinence (5%). A significant improvement (p < .05) in both International Consultation on Incontinence–Short Form and Incontinence Quality-of-Life Measure questionnaires was observed when making comparisons regarding the results before and after the EMG-BFB treatment protocol. These results support that male UI is significantly associated with urological and abdominal surgery (including radical prostatectomy) and that EMG-BFB for PFMT improves incontinence and quality of life (social embarrassment, limiting behavior, and psychosocial impact) in the three types of UI on an overall basis.

1 January 2019 in Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders
Verified
Journal Article
Open access
Marcos Edgar Fernandez-CuadrosMarcos Edgar Fernandez-Cuadros
Marcos Edgar Fernandez-Cuadros
LCLuz Otilia Casique-Bocanegra
Luz Otilia Casique-Bocanegra
MAMaría Jesús Albaladejo-Florín
María Jesús Albaladejo-Florín
SGSheila Gómez-Dueñas
Sheila Gómez-Dueñas
CRCarmen Ramos-Gonzalez
Carmen Ramos-Gonzalez
OPOlga Susana Pérez-Moro
Olga Susana Pérez-Moro
Since the introduction of Fluoroquinolones (FQ) in 1960s, these antibiotics have been used in airway and urinary tract infections, due to absorption, biodisponibility, posology and long half-life time properties. However, several reports state that FQ can cause tendinopathy and rupture. These adverse effects can occur within hours after initial treatment to up to 6 months after withdrawal. FQ-induced tendinopathy was first reported in 1983; since then more than 100 cases have been published. FQ usage can lead to complete tendon rupture and no more than 8 to 15 cases are reported worldwide. Most of rupture cases have been associated to corticoid use and rheumatic, vascular or renal disease. The purpose of this case report is to present the challenging diagnosis of a bilateral rupture of Achilles tendon in an old patient, because of the uncommon of the presentation and to review the current literature on such a debilitating condition.

10 January 2022 in Processes
Verified
Journal Article
Open access
PDF file
Marcos Edgar Fernandez-CuadrosMarcos Edgar Fernandez-Cuadros
Marcos Edgar Fernandez-Cuadros
OPOlga S. Pérez-Moro
Olga S. Pérez-Moro
MAMaría J. Albaladejo-Florín
María J. Albaladejo-Florín
MTMaría M. Tobar-Izquierdo
María M. Tobar-Izquierdo
AMAmelia Magaña-Sánchez
Amelia Magaña-Sánchez
JRJavier Rodríguez-De-Cía
Javier Rodríguez-De-Cía
Objectives: (1) to demonstrate the anti-inflammatory and anabolic effect of Ozone by determining in serum samples the biochemical levels of IL-6 and IGF-1 in knee osteoarthritis (OA) patients in a real world rehabilitation setting; (2) to differentiate Ozone effect in diabetic (DM)/obese and non-DM/non-obese patients; (3) to evaluate clinical effectiveness by visual analog scale (VAS) and WOMAC scale, and biochemical effect by C-reactive protein (CRP), uric acid and erythrocyte sedimentation rate (ESR). Material and methods: 65 patients with knee OA Kellgren Lawrence (KL) grade 2 or more were analyzed in a retrospective observational study. The study ran from January 2018 to September 2021. Inclusion criteria: (a) patients 18 years or older; (b) with knee OA KL 2° or more; (c) biochemical analysis before-and-after treatment; (d) pain more than 3 on VAS. Exclusion Criteria: (a) previous knee surgery; (b) favism; (c) pregnancy; (d) any other disease that originates lack of collaboration for infiltration. Primary Outcome variables: (a) IL-6; (b) IGF-1 in diabetes mellitus (DM)/obese and non-DM/non-obese patients; both before-and-after Ozone treatment. Secondary Outcome variables: (a) CRP, (b) ESR, (c) uric acid, (d) VAS pain, (e) WOMAC pain, function and stiffness. Ozone protocol consisted of four sessions (once a week) of an intra-articular infiltration of 20 mL (20 µg/mL concentration) of a gas mixture of Oxygen-Ozone 95-5% (produced by Ozone generator Ozonosan-α Plus®). For biochemical evaluation, SNIBE MAGLUMI ™ IL-6 (CLIA) and SNIBE MAGLUMI ™ IGF-1 (CLIA) kits were used. CRP and uric acid were analyzed by a Abbott Alinity c kit; and ESR was evaluated by DIESSE VES MATIC CUBE 30. Results: There is a linear correlation between age and OA severity. IL-6 decreased both in DM and non-DM patients and in all OA KL grades (from 2.70 to 1.59 pg/mL). IGF-1 decreased in total group (OA + DM + obesity) from 112.09 to 107.19 ng/mL. When only non-DM/non-obese knee OA patients were analyzed, Ozone improved IGF-1 levels (from 100.17 to 102.03 ng/mL). Ozone decreased CRP, ESR, uric acid, and improved VAS pain, WOMAC pain, function and stiffness (p < 0.05). Conclusions: Ozone is a valid option for the management of knee osteoarthritis in a real world rehabilitation setting, because of its anti-inflammatory, metabolic and anabolic properties. Ozone tends to downregulate pro-inflammatory IL-6 cytokine. Ozone has a metabolic/hypoglycemic effect on obese/diabetic knee osteoarthritis patients by reducing IGF-1. Ozone has an anabolic effect on non-diabetic/non-obese patients by improving IGF-1. Ozone reduces other biomarkers of inflammation (CRP, ESR and uric acid) and improves, pain, function and quality of life.